Most Read Articles
Rachel Soon, 22 Mar 2019

At the recent forum “Improving Access to Affordable Cancer Treatments in Malaysia”, the issue of treatment costs was discussed by panellists from the Ministry of Health (MOH) and pharmaceutical industry representatives.

18 Mar 2019
Aspirin use is associated with a lower risk of glioma, according to data from the Glioma International Case-Control Study.
11 Apr 2019
Overall, 5-fluorouracil is more effective than imiquimod in reducing the risk of keratinocyte carcinoma, but there are no differences in the short- or long-term risk of subsequent site-specific keratinocyte carcinoma in a real-world practice setting, according to a new study.
18 Feb 2019
Supplementation with folic acid and vitamin B12 potentially contributes to an increased risk of colorectal cancer, according to data from the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) trial.

Older age, IBD duration as risk factors for colitis-associated neoplasia

11 Jan 2019

Among patients with inflammatory bowel disease (IBD), older age at the time of IBD diagnosis and longer disease duration are associated with a heightened risk of developing colitis-associated neoplasia, a study has found.

Researchers looked at 29 adult IBD patients who developed CAN, of whom 69.0 percent had ulcerative colitis and 31.0 percent had Crohn’s disease, and 87 non-CAN controls. They matched the two patient groups according to gender and IBD type. 

In the CAN group, eight patients (27.6 percent) had colorectal cancer (CRC), 20 (69.0 percent) had low-grade dysplasia and one (3.4 percent) had high-grade dysplasia. Compared with controls, CAN patients were older at the time of IBD diagnosis (49.9 vs 36.9 years; p<0.001) and had longer duration of IBD (3.4 vs 2.1 years; p=0.35).

Multivariate logistic regression analysis confirmed that the development of CAN was significantly associated with older age at the time of IBD diagnosis (odds ratio [OR], 1.09; 95 percent CI, 1.04–1.14; p<0.001) and longer IBD disease duration (OR, 1.14; 1.03–1.27; p=0.013).

The observed associations were more pronounced in IBD patients with CRC (age at diagnosis, p=0.012; disease duration, p=0.019) than in those with dysplasia.

These results should be interpreted in light of potential limitations, particularly the retrospective study design, researchers noted. Nevertheless, the data may serve as a springboard for developing a risk-prediction model, which can be applied in daily clinical practice for an individualized approach to CAN surveillance in IBD patients.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 22 Mar 2019

At the recent forum “Improving Access to Affordable Cancer Treatments in Malaysia”, the issue of treatment costs was discussed by panellists from the Ministry of Health (MOH) and pharmaceutical industry representatives.

18 Mar 2019
Aspirin use is associated with a lower risk of glioma, according to data from the Glioma International Case-Control Study.
11 Apr 2019
Overall, 5-fluorouracil is more effective than imiquimod in reducing the risk of keratinocyte carcinoma, but there are no differences in the short- or long-term risk of subsequent site-specific keratinocyte carcinoma in a real-world practice setting, according to a new study.
18 Feb 2019
Supplementation with folic acid and vitamin B12 potentially contributes to an increased risk of colorectal cancer, according to data from the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) trial.